Search Results

You are looking at 1 - 7 of 7 items for

  • Author: J. A. F. Tresguerres x
  • Refine by access: All content x
Clear All Modify Search
J. A. F. TRESGUERRES
Search for other papers by J. A. F. TRESGUERRES in
Google Scholar
PubMed
Close
and
A. I. ESQUIFINO
Search for other papers by A. I. ESQUIFINO in
Google Scholar
PubMed
Close

Male and female Wistar rats were made hyperprolactinaemic by grafting two pituitary glands of litter-mate donors under the kidney capsule at 30 days of age. Other animals were sham-operated at the same age to serve as controls. Plasma levels of prolactin, LH and FSH were measured by double-antibody radioimmunoassay. Basal preoperative prolactin levels of ∼ 10 ng/ml increased after the transplantation in both male and female rats, reaching values of ∼ 180 ng/ml. Levels of LH were significantly reduced in these hyperprolactinaemic rats, whereas an increase in FSH values was seen. After administration of LH releasing hormone (LH-RH) a reduced LH response was seen but there was no response of FSH to LH-RH or even a decrease in FSH values. Prolactin levels were also reduced by LH-RH injection. Although an increase in prolactin levels was observed in control animals after a challenge with oestradiol benzoate, reduced increments were seen in experimental animals. The positive feedback effect of oestradiol benzoate on LH in females was reduced in pituitary-grafted rats but a potentiation of the FSH positive feedback could be clearly detected. This study suggests a dissociation of LH and FSH regulation in hyperprolactinaemia.

Restricted access
A. I. Esquifino
Search for other papers by A. I. Esquifino in
Google Scholar
PubMed
Close
,
J. A. Ramos
Search for other papers by J. A. Ramos in
Google Scholar
PubMed
Close
, and
J. A. F. Tresguerres
Search for other papers by J. A. F. Tresguerres in
Google Scholar
PubMed
Close

ABSTRACT

Nine-month-old female rats bearing an ectopic pituitary gland (from a litter-mate) under the right kidney capsule since day 30 of life and their sham-operated controls, were treated with a dopamine agonist (lysuride) or antagonist (metoclopramide). Plasma prolactin and LH levels were measured by double-antibody radioimmunoassays. Vaginal smears were taken before and during the treatment periods. Eight months after the operation, a significant (P < 0·01) increase in basal prolactin levels together with a significant (P < 0·05) reduction in LH values and permanent dioestrus occurred in the grafted animals when compared with controls. Lysuride treatment resulted in a marked reduction in plasma prolactin levels both in control and grafted rats over the whole 12 days of treatment, together with a partial restoration of plasma LH levels on day 1. From day 7 onwards a depression in LH values was again observed. Oestrous cycles were partially restored at the beginning of the treatment, but after 7 days dioestrus returned. Metoclopramide administration induced a significant (P< 0·001) increase in basal prolactin levels in both grafted and control rats. Basal plasma LH values were unaffected in controls when compared with vehicle-treated animals. An increase could be seen in hyperprolactinaemic rats after 7 or 12 days of treatment however. The LH response to the administration of LH releasing hormone (LHRH) was greater in the experimental and control metoclopramide-treated rats when compared with vehicle-treated rats. Vaginal smears were not altered in the control animals but there was a significant increase in the number of oestrous smears in grafted animals given the dopamine antagonist partially restoring the cycle pattern. After LHRH administration plasma prolactin levels decreased in vehicle-treated grafted and control animals, whereas only a tendency to lower values or no modification in basal levels was observed with lysuride or metoclopramide treatments. All these data suggest that increased plasma prolactin levels cannot modify LH secretion directly. This influence may be exerted, however, through increased hypothalamic and in-situ pituitary dopamine detected in hyperprolactinaemic animals.

J. Endocr. (1984) 100, 141–148

Restricted access
J. A. F. Tresguerres
Search for other papers by J. A. F. Tresguerres in
Google Scholar
PubMed
Close
,
L. F. Perez Mendez
Search for other papers by L. F. Perez Mendez in
Google Scholar
PubMed
Close
,
A. Lopez-Calderon
Search for other papers by A. Lopez-Calderon in
Google Scholar
PubMed
Close
, and
A. I. Esquifino
Search for other papers by A. I. Esquifino in
Google Scholar
PubMed
Close

ABSTRACT

To study the role of testosterone on the regulation of the hypothalamic-pituitary-testicular axis, young intact male Wistar rats were given acute (24 h) or chronic (5 days) subcutaneous treatments of 500 μg testosterone propionate (TP) or vehicle alone. Plasma LH, prolactin and testosterone levels were measured both basally and after administration of LH-releasing hormone (LHRH) or human chorionic gonadotrophin (hCG) by means of specific radioimmunoassay systems using materials supplied by the NIADDK. After acute treatment with TP there was an increase in basal plasma testosterone concentrations and no modification in the hCG response when compared with vehicle-treated animals. No difference could be detected in basal plasma testosterone levels after the chronic treatment, but a significant reduction in the hCG response was observed. Both acute and chronic treatments with TP resulted in a significant decrease of basal plasma LH levels. A reduced LH response to LHRH in acutely treated rats and no response in the chronically treated rats was detected. Plasma prolactin levels showed an increase after both acute and chronic treatments. To evaluate the possible role of the increased plasma prolactin levels on the above modifications during TP treatment, another group of animals was treated with TP and bromocriptine (dopamine agonist) simultaneously to avoid the increase in plasma prolactin levels. In this situation, neither basal plasma LH levels nor the response to LHRH were altered when compared to vehicle-treated rats; a normal testosterone response to hCG stimulation was observed in spite of the high basal plasma testosterone levels. All these observations suggest that increased prolactin levels may exert a modulatory role on the negative feedback effect of testosterone both at the testicular and central levels.

J. Endocr. (1985) 105, 423–427

Restricted access
A. López-Calderón
Search for other papers by A. López-Calderón in
Google Scholar
PubMed
Close
,
M. I. Gonzaléz-Quijano
Search for other papers by M. I. Gonzaléz-Quijano in
Google Scholar
PubMed
Close
,
J. A. F. Tresguerres
Search for other papers by J. A. F. Tresguerres in
Google Scholar
PubMed
Close
, and
C. Ariznavarreta
Search for other papers by C. Ariznavarreta in
Google Scholar
PubMed
Close

ABSTRACT

A hypothalamic site of action has been hypothesized for the inhibitory effect of chronic stress on gonadotrophin secretion. The aim of the present study was to examine the temporal changes in hypothalamic LHRH content and gonadotrophin secretion during restraint stress, and the pituitary responsiveness to LHRH stimulation in chronically stressed rats. Adult male rats were killed after being restrained for 0, 20, 45, 90, 180 and 360 min or for 6 h daily over 2, 3 and 4 days. After 20–45 min of stress there was an increase in plasma concentrations of LH (P<0·01) and a decrease in hypothalamic LHRH content (P<0·01), suggesting a negative correlation between plasma LH and hypothalamic LHRH concentrations. Plasma concentrations of FSH were also increased by restraint, but the FSH response was slower and less than the plasma LH response, being significant after 90 min of restraint. Plasma LH and FSH and hypothalamic LHRH concentrations were decreased in chronically stressed rats. In rats restrained for 6 h daily over 4 days, the response of plasma gonadotrophins to administration of 500 ng LHRH was enhanced 45 min after the injection. On the basis of these observations we concluded that in the intact rat, stress may acutely stimulate LHRH and gonadotrophin secretion, and the inhibitory effect of chronic stress on plasma LH and FSH seems not to be due to a reduction in pituitary responsiveness to LHRH, but rather to a decrease in LHRH secretion.

Journal of Endocrinology (1990) 124, 241–246

Restricted access
C. Ariznavarreta
Search for other papers by C. Ariznavarreta in
Google Scholar
PubMed
Close
,
M. D. Calderón
Search for other papers by M. D. Calderón in
Google Scholar
PubMed
Close
,
J. A. F. Tresguerres
Search for other papers by J. A. F. Tresguerres in
Google Scholar
PubMed
Close
, and
A. López-Calderón
Search for other papers by A. López-Calderón in
Google Scholar
PubMed
Close

ABSTRACT

In order to study the involvement of the adrenal medulla in stress-induced inhibition of gonadotrophin secretion, we measured plasma concentrations of LH, FSH and corticosterone in adult male rats subjected to chronic restraint after surgical ablation of the adrenal medulla. In intact animals, chronic restraint (6 h daily over 4 days) induced a significant (P<0.05) decrease in plasma concentrations of LH, whereas plasma concentrations of corticosterone showed the expected significant (P<0.01) increase. Adrenomedullectomy did not significantly modify basal plasma concentrations of LH or corticosterone. In these rats, there was no significant decrease of LH after stress, while the increase in corticosterone was as significant as in sham-operated animals (P<0.01). In order to confirm the role of adrenomedullary catecholamines in stress-induced gonadotrophin inhibition another group of rats was treated s.c. with the β-adrenergic blocker propranolol (2 mg/kg twice daily). These rats showed an attenuated inhibition of LH during stress similar to that observed in adrenomedullectomized rats. Levels of FSH were significantly reduced after stress in the saline-treated group, while there were no differences between stressed or unstressed rats in the propranolol-treated group. These results may be considered as evidence that medullary catecholamines, acting through β-receptors, are factors involved in gonadotrophin inhibition during chronic stress.

Journal of Endocrinology (1989) 120, 275–279

Restricted access
J. J. Fernández-Ruiz
Search for other papers by J. J. Fernández-Ruiz in
Google Scholar
PubMed
Close
,
M. Cebeira
Search for other papers by M. Cebeira in
Google Scholar
PubMed
Close
,
C. Agrasal
Search for other papers by C. Agrasal in
Google Scholar
PubMed
Close
,
J. A. F. Tresguerres
Search for other papers by J. A. F. Tresguerres in
Google Scholar
PubMed
Close
,
A. Bartke
Search for other papers by A. Bartke in
Google Scholar
PubMed
Close
,
A. I. Esquifino
Search for other papers by A. I. Esquifino in
Google Scholar
PubMed
Close
, and
J. A. Ramos
Search for other papers by J. A. Ramos in
Google Scholar
PubMed
Close

ABSTRACT

It was recently reported that anterior pituitary tissue transplanted to an ectopic site contains measurable amounts of dopamine and noradrenaline. To examine the possibility of local catecholaminergic control of prolactin secretion from ectopic pituitaries, pituitary grafted and sham-operated female rats were submitted to several pharmacological treatments modifying catecholamine synthesis. Administration of a single dose of α-methyl-p-tyrosine (α-MPT) significantly reduced dopamine content in the graft, while noradrenaline content was not modified. Similar changes in the contents of dopamine and noradrenaline after α-MPT administration were observed in the hypothalamus and in the in-situ pituitary in both grafted and sham-operated rats. Plasma concentrations of prolactin were increased in both grafted and sham-operated rats after administration of α-MPT. A single injection of l-3,4-dihydroxyphenylalanine (l-DOPA) increased dopamine content in the ectopic pituitary gland without altering the noradrenaline content, and produced similar effects in the hypothalamus and in-situ pituitary of grafted and control rats. Plasma prolactin concentrations were decreased by l-DOPA in both pituitary grafted and control rats. Administration of dl-treo-dihydroxyphenylserine (DOPS) increased noradrenaline content in the ectopic pituitary and reduced plasma prolactin concentrations in pituitary grafted rats. In contrast, injection of DOPS to control rats increased both hypothalamic noradrenaline content and plasma prolactin concentrations. These results suggest that dopamine and noradrenaline present in the ectopic pituitary tissue have a role in mediating prolactin release from pituitary transplants.

J. Endocr. (1987) 113, 45–49

Restricted access
A. López-Calderón
Search for other papers by A. López-Calderón in
Google Scholar
PubMed
Close
,
C. Ariznavarreta
Search for other papers by C. Ariznavarreta in
Google Scholar
PubMed
Close
,
M. D. Calderón
Search for other papers by M. D. Calderón in
Google Scholar
PubMed
Close
,
J. A. F. Tresguerres
Search for other papers by J. A. F. Tresguerres in
Google Scholar
PubMed
Close
, and
M. I. Gonzalez-Quijano
Search for other papers by M. I. Gonzalez-Quijano in
Google Scholar
PubMed
Close

ABSTRACT

The response of prolactin to chronic stress in intact, adrenalectomized and adrenomedullectomized male rats was studied. Immobilization stress in intact animals induced a significant increase in plasma concentrations of prolactin after 20 and 45 min and a significant decrease when the rats were submitted to chronic restraint (6 h daily for 4 days). Five weeks after adrenomedullectomy, plasma prolactin and corticosterone responses to chronic stress were not modified. In contrast, the inhibitory effect of chronic stress on prolactin secretion was totally suppressed by adrenalectomy. When treated with dexamethasone during the 4 days of restraint, adrenalectomized stressed rats showed similar plasma concentrations of prolactin to the intact stressed rats. These data indicate that the adrenal cortex is able to play an inhibitory role on prolactin secretion during stress only through a prolonged release of glucocorticoids.

Journal of Endocrinology (1989) 120, 269–273

Restricted access